中轴型脊柱关节炎的远程监测或患者发起照护:三臂随机对照非劣效性试验
在挪威门诊招募接受肿瘤坏死因子抑制剂稳定治疗且处于低疾病活动度的中轴型脊柱关节炎患者,随机分为远程监测、患者发起照护或常规照护三组,随访18个月。三种策略维持ASDAS<2.1的概率差异均在15%非劣效界值内,远程监测和患者发起照护非劣效于常规照护,支持实施新型随访策略。
要点
- 远程监测和患者发起照护在维持低疾病活动度方面非劣效于常规照护。
- 三组在6、12、18个月时均有90%以上患者ASDAS<2.1。
- 患者发起照护组的卫生提供者资源使用最低。
核心结论
- 在接受肿瘤坏死因子抑制剂稳定治疗且处于低疾病活动度的中轴型脊柱关节炎患者中,远程监测或患者发起照护随访在维持低疾病活动度方面非劣效于常规照护,支持实施新型随访策略。
研究设计与样本
- 随机、对照、三臂、平行组、开放标签、非劣效性试验,自挪威门诊招募接受肿瘤坏死因子抑制剂稳定治疗且处于低疾病活动度的中轴型脊柱关节炎患者。
- 患者按1:1:1随机分配至远程监测、患者发起照护或常规照护(对照组),随访18个月。
主要发现
- 243例入组患者中235例完成研究(远程监测=75,患者发起照护=79,常规照护=81)。
- 在6个月、12个月和18个月评估时,三组均有90%以上患者ASDAS<2.1。
- ASDAS<2.1概率的估计差值:常规照护 vs 远程监测为-4.1%(97.5%CI,-9.9%至1.8%);常规照护 vs 患者发起照护为-1.1%(97.5%CI,-7.2%至4.9%);远程监测 vs 患者发起照护为2.9%(95%CI,-1.5%至7.4%)。
- 卫生提供者资源使用在患者发起照护组最低;其他次要结局相当。
关键数值与推荐
- 主要结局为ASDAS<2.1的平均概率,在6、12和18个月时组间比较,非劣效界值为15%。
- 次要结局包括其他疾病活动度指标、身体功能、患者满意度、用药变化、资源使用和不良事件。
临床怎么用
- 原文结论支持实施远程监测或患者发起照护等新型随访策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to determine whether novel follow-up regimen, remote monitoring, or patient-initiated care is noninferior to usual care in maintaining low disease activity, in patients with axial spondyloarthritis (axSpA). METHODS: This is a randomised, controlled, 3-armed, parallel-group, open-label, noninferiority trial. Patients with axSpA in low disease activity on stable treatment with tumour necrosis factor inhibitor were recruited from a Norwegian outpatient clinic. Patients were randomly allocated 1:1:1 to remote monitoring, patient-initiated care, or usual care (control group), with 18 months of follow-up. Primary outcome was mean probability of axSpA Disease Activity Score (ASDAS) of <2.1, compared between groups at 6, 12, and 18 months, with 15% noninferiority margin. Secondary outcomes included other measures of disease activity, physical function, patient satisfaction, change of medication, resource use, and adverse events. RESULTS: Of 243 patients enrolled patients, 235 completed the study (remote monitoring = 75, patient-initiated care = 79, usual care = 81). At the 6-month, 12-month, and 18-month assessments, 90% or more patients in all 3 groups had ASDAS of <2.1. The estimated difference of probability of ASDAS < 2.1 was as follows: usual care vs remote monitoring, -4.1% (97.5% CI, -9.9% to 1.8%); usual care vs patient-initiated care, -1.1% (97.5% CI, -7.2% to 4.9%); and remote monitoring vs patient-initiated care, 2.9% (95% CI, -1.5% to 7.4%). Health providers' resource use was lowest in patient-initiated care; other secondary outcomes were comparable. CONCLUSIONS: In patients with axSpA in low disease activity and on stable treatment with tumour necrosis factor inhibitor, follow-up with remote monitoring or patient-initiated care was noninferior to usual care in maintaining low disease activity, supporting the implementation of novel follow-up strategies.
引用
- Berg IJ, Kristianslund EK, Tveter AT, et al. Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial. Ann Rheum Dis. 2025. PMID: 40413111. doi:10.1016/j.ard.2025.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。